Nicely fitting with these data, the blockade of IL-8 by a neutralizing antibody or the inhibition of CXCR1/2, blunted tumor growth and metastasis, and also reversed the resistance to treatments in breast cancer [89,91,94,126]. Here, CXCR1 is linked to breast carcinoma.